- Home
- SNPX vs APDN Comparison
SNPX vs APDN Comparison
Compare SNPX & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNPX
- APDN
- Stock Information
- Founded
- SNPX 2012
- APDN 1983
- Country
- SNPX United States
- APDN United States
- Employees
- SNPX N/A
- APDN N/A
- Industry
- SNPX Medicinal Chemicals and Botanical Products
- APDN Other Consumer Services
- Sector
- SNPX Health Care
- APDN Consumer Discretionary
- Exchange
- SNPX Nasdaq
- APDN Nasdaq
- Market Cap
- SNPX 4.1M
- APDN 3.3M
- IPO Year
- SNPX N/A
- APDN N/A
- Fundamental
- Price
- SNPX $2.40
- APDN $0.16
- Analyst Decision
- SNPX Strong Buy
- APDN Strong Buy
- Analyst Count
- SNPX 1
- APDN 1
- Target Price
- SNPX $14.00
- APDN $1.50
- AVG Volume (30 Days)
- SNPX 18.6K
- APDN 4.9M
- Earning Date
- SNPX 11-12-2024
- APDN 12-05-2024
- Dividend Yield
- SNPX N/A
- APDN N/A
- EPS Growth
- SNPX N/A
- APDN N/A
- EPS
- SNPX N/A
- APDN N/A
- Revenue
- SNPX N/A
- APDN $3,398,049.00
- Revenue This Year
- SNPX N/A
- APDN N/A
- Revenue Next Year
- SNPX N/A
- APDN $48.01
- P/E Ratio
- SNPX N/A
- APDN N/A
- Revenue Growth
- SNPX N/A
- APDN N/A
- 52 Week Low
- SNPX $2.32
- APDN $0.15
- 52 Week High
- SNPX $8.78
- APDN $22.80
- Technical
- Relative Strength Index (RSI)
- SNPX 33.10
- APDN 28.68
- Support Level
- SNPX $2.88
- APDN $0.17
- Resistance Level
- SNPX $3.20
- APDN $0.21
- Average True Range (ATR)
- SNPX 0.19
- APDN 0.02
- MACD
- SNPX -0.06
- APDN 0.02
- Stochastic Oscillator
- SNPX 8.88
- APDN 9.09
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.